Q1 2016 Holdings
Filed 2016-05-06 | 23 holdings | $5.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ardelyx, Inc.(ARDX) | COM | 039697107 | $5.0M | 648,340 | 97.6% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $31.3K | 1,278,570 | 0.6% |
| Wave Life Sciences Ltd.(WVE) | SHS | Y95308105 | $17.9K | 1,411,749 | 0.3% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $11.6K | 957,126 | 0.2% |
| Global Blood Therapeutics, Inc. | COM | 37890U108 | $7.9K | 497,000 | 0.2% |
| Zafgen, Inc. | COM | 98885E103 | $7.0K | 1,050,837 | 0.1% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $5.8K | 476,777 | 0.1% |
| Regulus Therapeutics Inc. | COM | 75915K101 | $5.5K | 789,091 | 0.1% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $4.8K | 355,020 | 0.1% |
| Avexis, Inc. | COM | 05366U100 | $4.6K | 168,195 | 0.1% |
| NeuroDerm Ltd. | ORD SHS | M74231107 | $4.1K | 292,371 | 0.1% |
| Lipocine Inc. | COM | 53630X104 | $4.0K | 397,107 | 0.1% |
| Akari Therapeutics, PLC | SPONSORED ADR | 00972G108 | $3.7K | 263,921 | 0.1% |
| Sangamo Biosciences, Inc.(SGMO) | COM | 800677106 | $3.3K | 544,816 | 0.1% |
| Intersect ENT, Inc. | COM | 46071F103 | $3.2K | 168,550 | 0.1% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $2.5K | 94,403 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $1.9K | 205,990 | 0.0% |
| Orexigen Therapeutics, Inc. | COM | 686164104 | $1.7K | 3,027,354 | 0.0% |
| Regenxbio Inc.(RGNX) | COM | 75901B107 | $1.1K | 100,000 | 0.0% |
| Dimension Therapeutics, Inc. | COM | 25433V105 | $770 | 98,297 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | COM | 09060J106 | $670 | 207,498 | 0.0% |
| Editas Medicine, Inc.(EDIT) | COM | 28106W103 | $501 | 14,500 | 0.0% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $365 | 42,815 | 0.0% |